{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:53:05Z","timestamp":1784947985143,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"U.S. President's Malaria Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13071-019-3549-x","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T15:02:53Z","timestamp":1560178973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection"],"prefix":"10.1186","volume":"12","author":[{"given":"Mateusz M.","family":"Plucinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Rafael","family":"Dimbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomeno","family":"Fortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Nace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Halsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rogier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"3549_CR1","volume-title":"Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 7 (2015\u20132016)","author":"WHO","year":"2017","unstructured":"WHO. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 7 (2015\u20132016). Geneva: World Health Organization; 2017."},{"key":"3549_CR2","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1017\/S0031182014001371","volume":"141","author":"PL Chiodini","year":"2014","unstructured":"Chiodini PL. Malaria diagnostics: now and the future. Parasitology. 2014;141:1873\u20139.","journal-title":"Parasitology"},{"key":"3549_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/infdis\/jix622","volume":"217","author":"MM Plucinski","year":"2018","unstructured":"Plucinski MM, Dimbu PR, Fortes F, Abdulla S, Ahmed S, Gutman J, et al. Post-treatment HRP2 clearance in patients with uncomplicated Plasmodium falciparum malaria. J Infect Dis. 2018;217:685\u201392.","journal-title":"J Infect Dis"},{"key":"3549_CR4","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1371\/journal.pmed.0020204","volume":"2","author":"AM Dondorp","year":"2005","unstructured":"Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005;2:e204.","journal-title":"PLoS Med"},{"key":"3549_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4269\/ajtmh.2005.73.199","volume":"73","author":"DR Bell","year":"2005","unstructured":"Bell DR, Wilson DW, Martin LB. False-positive results of a Plasmodium falciparum histidine-rich protein 2-detecting malaria rapid diagnostic test due to high sensitivity in a community with fluctuating low parasite density. Am J Trop Med Hyg. 2005;73:199\u2013203.","journal-title":"Am J Trop Med Hyg"},{"key":"3549_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1128\/JCM.39.3.1025-1031.2001","volume":"39","author":"E Tjitra","year":"2001","unstructured":"Tjitra E, Suprianto S, McBroom J, Currie BJ, Anstey NM. Persistent ICT malaria Pf\/Pv panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence. J Clin Microbiol. 2001;39:1025\u201331.","journal-title":"J Clin Microbiol"},{"key":"3549_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/infdis\/jix623","volume":"217","author":"OA Koita","year":"2018","unstructured":"Koita OA, Krogstad DJ. Converting a liability to an asset: using the clearance of a malaria parasite protein from the blood of infected subjects to predict the outcome of treatment. J Infect Dis. 2018;217:683\u20134.","journal-title":"J Infect Dis"},{"key":"3549_CR8","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1128\/JCM.42.9.4237-4241.2004","volume":"42","author":"J Iqbal","year":"2004","unstructured":"Iqbal J, Siddique A, Jameel M, Hira PR. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J Clin Microbiol. 2004;42:4237\u201341.","journal-title":"J Clin Microbiol"},{"key":"3549_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1475-2875-12-349","volume":"12","author":"B Aydin-Schmidt","year":"2013","unstructured":"Aydin-Schmidt B, Mubi M, Morris U, Petzold M, Ngasala BE, Premji Z, et al. Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy. Malar J. 2013;12:349.","journal-title":"Malar J"},{"key":"3549_CR10","doi-asserted-by":"publisher","first-page":"e56828","DOI":"10.1371\/journal.pone.0056828","volume":"8","author":"IM Bashir","year":"2013","unstructured":"Bashir IM, Otsyula N, Awinda G, Spring M, Schneider P, Waitumbi JN. Comparison of PfHRP-2\/pLDH ELISA, qPCR and microscopy for the detection of Plasmodium events and prediction of sick visits during a malaria vaccine study. PLoS ONE. 2013;8:e56828.","journal-title":"PLoS ONE"},{"key":"3549_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, et al. Efficacy of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16:62.","journal-title":"Malar J"},{"key":"3549_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Joao MF, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17:144.","journal-title":"Malar J"},{"key":"3549_CR13","doi-asserted-by":"publisher","first-page":"e0172139","DOI":"10.1371\/journal.pone.0172139","volume":"12","author":"E Rogier","year":"2017","unstructured":"Rogier E, Plucinski M, Lucchi N, Mace K, Chang M, Lemoine JF, et al. Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests. PLoS ONE. 2017;12:e0172139.","journal-title":"PLoS ONE"},{"key":"3549_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/infdis\/jiy525","volume":"219","author":"MM Plucinski","year":"2018","unstructured":"Plucinski MM, Herman C, Jones S, Dimbu R, Fortes F, Ljolje D, et al. Screening for Pfhrp2\/3-deleted Plasmodium falciparum, non-falciparum, and low-density malaria infections by a multiplex antigen assay. J Infect Dis. 2018;219:437\u201347.","journal-title":"J Infect Dis"},{"key":"3549_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0166-6851(99)00087-0","volume":"102","author":"C Wanidworanun","year":"1999","unstructured":"Wanidworanun C, Nagel RL, Shear HL. Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum. Mol Biochem Parasitol. 1999;102:91\u2013101.","journal-title":"Mol Biochem Parasitol"},{"key":"3549_CR16","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1021\/jm980334n","volume":"41","author":"LM Deck","year":"1998","unstructured":"Deck LM, Royer RE, Chamblee BB, Hernandez VM, Malone RR, Torres JE, et al. Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum. J Med Chem. 1998;41:3879\u201387.","journal-title":"J Med Chem"},{"key":"3549_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1083\/jcb.103.4.1269","volume":"103","author":"RJ Howard","year":"1986","unstructured":"Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol. 1986;103:1269\u201377.","journal-title":"J Cell Biol"},{"key":"3549_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12936-019-2712-3","volume":"18","author":"KE Poti","year":"2019","unstructured":"Poti KE, Balaban AE, Pal P, Kobayashi T, Goldberg DE, Sinnis P, et al. In vivo compartmental kinetics of Plasmodium falciparum histidine-rich protein II in the blood of humans and in BALB\/c mice infected with a transgenic Plasmodium berghei parasite expressing histidine-rich protein II. Malar J. 2019;18:78.","journal-title":"Malar J"},{"key":"3549_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0031182005008085","volume":"131","author":"L Ochola","year":"2005","unstructured":"Ochola L, Marsh K, Lowe B, Gal S, Pluschke G, Smith T. Estimation of the sequestered parasite load in severe malaria patients using both host and parasite markers. Parasitology. 2005;131:449\u201358.","journal-title":"Parasitology"},{"key":"3549_CR20","doi-asserted-by":"publisher","first-page":"01901","DOI":"10.1128\/JCM.01901-18","volume":"57","author":"MM Plucinski","year":"2019","unstructured":"Plucinski MM, Rogier E, Dimbu R, Fortes F, Halsey ES, Aidoo M, et al. Performance of antigen concentration thresholds for attributing fever to malaria among outpatients in Angola. J Clin Microbiol. 2019;57:01901\u201318.","journal-title":"J Clin Microbiol"},{"key":"3549_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jama.280.1.42","volume":"280","author":"RS Janssen","year":"1998","unstructured":"Janssen RS, Satten GA, Stramer SL, Rawal BD, O\u02bcbrien TR, Weiblen BJ, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42\u20138.","journal-title":"JAMA"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3549-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:25:55Z","timestamp":1591658755000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3549"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3549-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original therapeutic efficacy studies were approved by human subjects review boards at the Centers for Disease Control and Prevention and the Angolan Ministry of Health. Additional antigen detection in the previously-collected samples was approved by the office of the Associate Director of Science in the Center for Global Health at the Centers for Disease Control and Prevention.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read the final manuscript and provided consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they do not have any commercial or other associations that might pose a competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}